Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
D000172:Acromegaly / Q000188:drug therapy / Q000503:physiopathology*; D000547:Amantadine / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007980:Levodopa / Q000627:therapeutic use*; D010646:Phentolamine / Q000627:therapeutic use; D010902:Pituitary Gland / Q000378:metabolism* / Q000503:physiopathology; D011433:Propranolol / Q000627:therapeutic use
D004873:Ergolines; D001971:Bromocriptine; D007980:Levodopa; D013006:Growth Hormone; D011433:Propranolol; D000547:Amantadine; D010646:Phentolamine